参考文献/References:
[1] Fidler MM,Reulen RC,Henson K,et al. Population-based long-term cardiac-specific mortality among 34 489 five-year survivors of childhood cancer in great britain[J]. Circulation,2017,135(10):951-963.
[2] McGale P,Darby SC,Hall P,et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden[J]. Radiother Oncol,2011,100(2):167-175.
[3]熊青松,凌智瑜. 心律失常射频导管消融的放射防护[J]. 心血管病学进展,2018,39(5):751-754.
[4] Mulrooney DA,Armstrong GT,Huang S,et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy:a cross-sectional study[J]. Ann Intern Med,2016,164(2):93-101.
[5] Boero IJ,Paravati AJ,Triplett DP,et al. Modern radiation therapy and cardiac outcomes in breast cancer[J]. Int J Radiat Oncol Biol Phys,2016,94(4):700-708.
[6] Preston DL,Shimizu Y,Pierce DA,et al. Studies of mortality of atomic bomb survivors. Report 13:solid cancer and noncancer disease mortality:1950-1997. 2003[J]. Radiat Res,2012,178(2):AV146-172.
[7] Yusuf SW,Sami S,Daher IN. Radiation-induced heart disease:a clinical update[J]. Cardiol Res Pract,2011,2011:1-9.
[8] Yentrapalli R,Azimzadeh O,Sriharshan A,et al. The PI3K/Akt/mTOR pathway is implicated in the premature senescence of primary human endothelial cells exposed to chronic radiation[J]. PLoS One,2013,8(8):e70024.
[9] Mun GI,Boo YC. Identification of CD44 as a senescence-induced cell adhesion gene responsible for the enhanced monocyte recruitment to senescent endothelial cells[J]. Am J Physiol Heart Circ Physiol,2010,298(6):H2102-H2111.
[10] Halle M,Gabrielsen A,Paulsson-Berne G,et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries[J]. J Am Coll Cardiol,2010,55(12):1227-1236.
[11] Dong X,Tong F,Qian C,et al. NEMO modulates radiation-induced endothelial senescence of human umbilical veins through NF-kappaB signal pathway[J] .Radiat Res,2015,183(1):82-93.
[12] Elmore S. Apoptosis:a review of programmed cell death[J]. Toxicol Pathol,2007,35(4):495-516.
[13] Seideman JH,Stancevic B,Rotolo JA,et al. Alpha particles induce apoptosis through the sphingomyelin pathway[J]. Radiat Res,2011,176(4):434-446.
[14] Prabhakarpandian B,Goetz DJ,Swerlick RA,et al. Expression and functional significance of adhesion molecules on cultured endothelial cells in response to ionizing radiation[J]. Microcirculation,2001,8(5):355-364.
[15] Pathak R,Wang J,Garg S,et al. Recombinant thrombomodulin (solulin) ameliorates early intestinal radiation toxicity in a preclinical rat model[J]. Radiat Res,2016,186(2):112-120.
[16] Sugihara T,Hattori Y,Yamamoto Y,et al. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation[J]. Circulation,1999,100(6):635-641.
[17] Beckman JS,Crow JP. Pathological implications of nitric oxide,superoxide and peroxynitrite formation[J]. Biochem Soc Trans,1993,21(2):330-334.
[18] Linard C,Marquette C,Mathieu J,et al. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat:effect of an NF-kappaB inhibitor[J]. Int J Radiat Oncol Biol Phys,2004,58(2):427-434.
[19] Mezzaroma E,Mikkelsen RB,Toldo S,et al. Role of interleukin-1 in radiation-induced cardiomyopathy[J]. Mol Med,2015,21:210-218.
[20] Venkatesulu BP,Mahadevan LS,Aliru ML,et al. Radiation-induced endothelial vascular injury:a review of possible mechanisms[J]. JACC Basic Transl Sci,2018,3(4):563-572.
[21] Darby SC,Ewertz M,McGale P,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer[J]. N Engl J Med,2013,368(11):987-998.
[22] Marks LB,Yu X,Prosnitz RG,et al. The incidence and functional consequences of RT-associated cardiac perfusion defects[J]. Int J Radiat Oncol Biol Phys,2005,63(1):214-223.
[23] Heidenreich PA,Schnittger I,Strauss HW,et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkins disease[J]. J Clin Oncol,2007,25(1):43-49.
[24] Caro-Codon J,Jimenez-Valero S,Galeote G,et al. Radiation-induced coronary artery disease:useful insights from OCT[J]. Int J Cardiol,2016,202:535-536.
[25] Brown ML,Schaff HV,Sundt TM. Conduit choice for coronary artery bypass grafting after mediastinal radiation[J]. J Thorac Cardiovasc Surg,2008,136(5):1167-1171.
[26] Brosius FC 3rd,Waller BF,Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart[J]. Am J Med,1981,70(3):519-530.
[27] Bijl JM,Roos MM,van Leeuwen-Segarceanu EM,et al. Assessment of valvular disorders in survivors of Hodgkins lymphoma treated by mediastinal radiotherapy +/- chemotherapy[J]. Am J Cardiol,2016,117(4):691-696.
[28] Cutter DJ,Schaapveld M,Darby SC,et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma[J]. J Natl Cancer Inst,2015,107(4):djv008-djv008.
[29] Heidenreich PA,Hancock SL,Lee BK,et al. Asymptomatic cardiac disease following mediastinal irradiation[J]. J Am Coll Cardiol,2003,42(4):743-749.
[30] Cuomo JR,Sharma GK,Conger PD,et al. Novel concepts in radiation-induced cardiovascular disease[J]. World J Cardiol,2016,8(9):504-519.
[31] Ogino I,Watanabe S,Iwahashi N,et al. Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer[J]. Strahlenther Onkol,2016,192(6):359-367.
[32] Hoit BD. Pathophysiology of the pericardium[J]. Prog Cardiovasc Dis,2017,59(4):341-348.
[33] Mousavi N,Nohria A. Radiation-induced cardiovascular disease[J]. Curr Treat Options Cardiovasc Med,2013,15(5):507-517.
[34] Yusuf SW,Hassan SA,Mouhayar E,et al. Pericardial disease:a clinical review[J]. Expert Rev Cardiovasc Ther,2016,14(4):525-539.
[35] Yusuf SW,Howell RM,Gomez D,et al. Radiation-related heart and vascular disease[J]. Future Oncol,2015,11(14):2067-2076.
[36] Guldner L,Haddy N,Pein F,et al. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer[J]. Radiother Oncol,2006,81(1):47-56.
[37] Al-Kindi SG,Oliveira GH. Heart transplantation outcomes in radiation-induced restrictive cardiomyopathy[J]. J Card Fail,2016,22(6):475-478.
[38] Marmagkiolis K,Finch W,Tsitlakidou D,et al. Radiation toxicity to the cardiovascular system[J]. Curr Oncol Rep,2016,18(3):15.
[39] Groarke JD,Tanguturi VK,Hainer J,et al. Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation:evidence of cardiac autonomic dysfunction and impact on outcomes[J]. J Am Coll Cardiol,2015,65(6):573-583.
[40] Hoca A,Yildiz M,Ozyigit G. Evaluation of the effects of mediastinal radiation therapy on autonomic nervous system[J]. Med Oncol,2012,29(5):3581-3586.
[41] Huang CC,Huang TL,Hsu HC,et al. Long-term effects of neck irradiation on cardiovascular autonomic function:a study in nasopharyngeal carcinoma patients after radiotherapy[J]. Muscle Nerve,2013,47(3):344-350.
[42] Aung T,Fan W,Krishnamurthy M. Recurrent syncope,orthostatic hypotension and volatile hypertension:think outside the box [J]. J Community Hosp Intern Med Perspect,2013,3(2):45-49.
[43] Lancellotti P,Nkomo VT,Badano LP,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults:a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography[J]. J Am Soc Echocardiogr,2013,26(9):1013-1032.
[44] 关旭敏,杨晓蕾,夏云龙. 心血管疾病危险因素对肿瘤的作用[J]. 心血管病学进展,2017,38(5):616-619.
[45] Doi H,Matsumoto S,Odawara S,et al. Pravastatin reduces radiation-induced damage in normal tissues[J]. Exp Ther Med,2017,13(5):1765-1772.
[46] Jang H,Lee J,Park S,et al. Pravastatin attenuates acute radiation-induced enteropathy and improves epithelial cell function[J]. Front Pharmacol,2018,9:1215.
[47] Ma CX,Zhao XK,Li YD. New therapeutic insights into radiation-induced myocardial fibrosis[J]. Ther Adv Chronic Dis,2019,10:2040622319868383.
相似文献/References:
[1]熊政 张阳扬 李群星 赵新华 邵杨歌 尹德录.放射性心脏病的治疗[J].心血管病学进展,2020,(5):476.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.009]
Treatment of Radiation-induced Heart Disease.[J].Advances in Cardiovascular Diseases,2020,(3):476.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.009]
[2]祁小青 周蕾.肿瘤治疗所致Ⅰ型心脏损伤的防治[J].心血管病学进展,2020,(7):741.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.017]
QI Xiaoqing,ZHOU Lei.Prevention and Treatment of TypeCardiac Injury Caused by Cancer Treatment[J].Advances in Cardiovascular Diseases,2020,(3):741.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.017]
[3]薛祚臣 程爱娟.心房颤动合并肿瘤患者的治疗现状及进展[J].心血管病学进展,2021,(9):773.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
XUE Zuochen,CHENG Aijuan.Status and Progress of Treatment in Patients with Atrial Fibrillation and Tumor[J].Advances in Cardiovascular Diseases,2021,(3):773.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[4]关晴 余陆娇 张子新.肿瘤心脏病康复[J].心血管病学进展,2022,(6):526.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.012]
GUAN Qing,YU Lujiao,ZHANG Zixin.Cardio-Oncology Rehabilitation[J].Advances in Cardiovascular Diseases,2022,(3):526.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.012]
[5]肖乾凤 王斯 刘燕扬 魏欣.免疫检查点抑制剂相关性心肌炎的诊治[J].心血管病学进展,2022,(7):610.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
Inhibitors-Related Myocarditis.Diagnosis and Treatment of Immune Checkpoint[J].Advances in Cardiovascular Diseases,2022,(3):610.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[6]陈媛 夏超睿 李景东.抗肿瘤药物所致心律失常的研究进展[J].心血管病学进展,2023,(5):445.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.014]
CHEN YuanXIA ChaoruiLI Jingdong.Antineoplastic Drugs Induced Arrhythmia[J].Advances in Cardiovascular Diseases,2023,(3):445.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.014]
[7]蒋弼瀛 黄佳宇 陈文佳.肿瘤相关血压的血压管理的研究进展[J].心血管病学进展,2024,(1):52.[doi:10.16806/j.cnki.issn.1004-3934.202.01.014]
JIANG Biying,HUANG Jiayu,CHEN Wenjia.Blood Pressure Management of Tumor-Associated Hypertension[J].Advances in Cardiovascular Diseases,2024,(3):52.[doi:10.16806/j.cnki.issn.1004-3934.202.01.014]
[8]漆峰林 王恩润 肖骅.心房颤动合并肿瘤治疗管理的双向影响现状[J].心血管病学进展,2024,(9):826.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.013]
QI Fenglin,WANG Enrun,XIAO Hua.Current Status of Bidirectional Effects of Therapeutic Management of Atrial Fibrillation Combined with Neoplasm[J].Advances in Cardiovascular Diseases,2024,(3):826.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.013]